• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期使用阿片类药物会增加既往有肝脏疾病患者肝损伤的风险吗?微生物群在其中起什么作用?

Could chronic opioid use be an additional risk of hepatic damage in patients with previous liver diseases, and what is the role of microbiome?

作者信息

Tarantino Giovanni, Cataldi Mauro, Citro Vincenzo

机构信息

Department of Clinical Medicine and Surgery, "Federico II" University Medical School of Naples, Naples, Italy.

Section of Pharmacology, Department of Neuroscience, Reproductive Sciences and Dentistry, Federico II University of Naples, Naples, Italy.

出版信息

Front Microbiol. 2024 Dec 2;15:1319897. doi: 10.3389/fmicb.2024.1319897. eCollection 2024.

DOI:10.3389/fmicb.2024.1319897
PMID:39687876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11646994/
Abstract

Among illicit drugs, addiction from opioids and synthetic opioids is soaring in an unparalleled manner with its unacceptable amount of deaths. Apart from these extreme consequences, the liver toxicity is another important aspect that should be highlighted. Accordingly, the chronic use of these substances, of which fentanyl is the most frequently consumed, represents an additional risk of liver damage in patients with underlying chronic liver disease. These observations are drawn from various preclinical and clinical studies present in literature. Several downstream molecular events have been proposed, but recent pieces of research strengthen the hypothesis that dysbiosis of the gut microbiota is a solid mechanism inducing and worsening liver damage by both alcohol and illicit drugs. In this scenario, the gut flora modification ascribed to non-alcoholic fatty liver disease performs an additive role. Interestingly enough, HBV and HCV infections impact gut-liver axis. In the end, the authors tried to solicit the attention of operators on this major healthcare problem.

摘要

在非法药物中,阿片类药物和合成阿片类药物成瘾现象正以前所未有的速度飙升,导致了令人无法接受的死亡人数。除了这些极端后果外,肝脏毒性是另一个需要强调的重要方面。因此,长期使用这些物质(其中芬太尼是最常被使用的)会给潜在慢性肝病患者带来额外的肝损伤风险。这些观察结果来自文献中各种临床前和临床研究。虽然已经提出了几种下游分子事件,但最近的研究进一步支持了这样一种假设,即肠道微生物群失调是酒精和非法药物诱导和加重肝损伤的一个可靠机制。在这种情况下,非酒精性脂肪性肝病引起的肠道菌群改变起到了累加作用。有趣的是,乙肝病毒和丙肝病毒感染会影响肠肝轴。最后,作者试图引起从业者对这一重大医疗问题的关注。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e270/11646994/ed9b0b60536d/fmicb-15-1319897-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e270/11646994/b51fd533aa29/fmicb-15-1319897-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e270/11646994/ed9b0b60536d/fmicb-15-1319897-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e270/11646994/b51fd533aa29/fmicb-15-1319897-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e270/11646994/ed9b0b60536d/fmicb-15-1319897-g002.jpg

相似文献

1
Could chronic opioid use be an additional risk of hepatic damage in patients with previous liver diseases, and what is the role of microbiome?长期使用阿片类药物会增加既往有肝脏疾病患者肝损伤的风险吗?微生物群在其中起什么作用?
Front Microbiol. 2024 Dec 2;15:1319897. doi: 10.3389/fmicb.2024.1319897. eCollection 2024.
2
The current findings on the gut-liver axis and the molecular basis of NAFLD/NASH associated with gut microbiome dysbiosis.目前关于肠-肝轴以及与肠道微生物群失调相关的非酒精性脂肪性肝病/非酒精性脂肪性肝炎分子基础的研究结果。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 9. doi: 10.1007/s00210-025-04069-z.
3
Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.回肠胆汁酸转运蛋白抑制剂通过改善非酒精性脂肪性肝病模型小鼠肠道微生物失调改善肝脂肪变性。
mBio. 2021 Aug 31;12(4):e0115521. doi: 10.1128/mBio.01155-21. Epub 2021 Jul 6.
4
Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.综述文章:肠道微生物组作为慢性肝病发病机制和治疗的治疗靶点。
Aliment Pharmacol Ther. 2018 Jan;47(2):192-202. doi: 10.1111/apt.14397. Epub 2017 Oct 30.
5
Gut dysbiosis correction contributes to the hepatoprotective effects of Celak extract against alcohol through the gut-liver axis.肠道菌群失调的纠正通过肠-肝轴有助于Celak提取物对酒精的肝脏保护作用。
Food Funct. 2021 Oct 19;12(20):10281-10290. doi: 10.1039/d1fo01117k.
6
Gut microbiota and host metabolism in liver cirrhosis.肝硬化中的肠道微生物群与宿主代谢
World J Gastroenterol. 2015 Nov 7;21(41):11597-608. doi: 10.3748/wjg.v21.i41.11597.
7
The role of morphine- and fentanyl-induced impairment of intestinal epithelial antibacterial activity in dysbiosis and its impact on the microbiota-gut-brain axis.吗啡和芬太尼诱导的肠道上皮抗菌活性损伤在肠道菌群失调及其对微生物群-肠-脑轴的影响中的作用。
FASEB J. 2024 Apr 30;38(8):e23603. doi: 10.1096/fj.202301590RR.
8
Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.慢性乙型肝炎感染相关肝病中肠道微生物组和代谢组学的改变及其对外周免疫反应的影响。
Gut Microbes. 2023 Jan-Dec;15(1):2155018. doi: 10.1080/19490976.2022.2155018.
9
Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies.非酒精性脂肪性肝病与肠道微生物失调:潜在机制和肠道微生物介导的治疗策略。
Rev Endocr Metab Disord. 2023 Dec;24(6):1189-1204. doi: 10.1007/s11154-023-09843-z. Epub 2023 Oct 16.
10
Gut Microbiome Dysbiosis in Alcoholism: Consequences for Health and Recovery.肠道微生物失调与酗酒:对健康和康复的影响。
Front Cell Infect Microbiol. 2022 Mar 3;12:840164. doi: 10.3389/fcimb.2022.840164. eCollection 2022.

引用本文的文献

1
Influence of a Zombie-like State of the Liver on Drugs and Its Medico-Legal Implications: A Scoping Review.肝脏类僵尸状态对药物的影响及其法医学意义:一项范围综述
Pharmaceuticals (Basel). 2025 May 24;18(6):787. doi: 10.3390/ph18060787.

本文引用的文献

1
What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?酒精性和非酒精性脂肪肝的下游常见分子事件有哪些?
Lipids Health Dis. 2024 Feb 8;23(1):41. doi: 10.1186/s12944-024-02031-1.
2
Thyroid function and opium use disorder: a cross-sectional study on the Fasa adults cohort study (FACS), 2017.甲状腺功能与阿片类物质使用障碍:2017 年法萨成年人队列研究(FACS)的横断面研究
BMC Endocr Disord. 2023 Nov 30;23(1):264. doi: 10.1186/s12902-023-01467-3.
3
Trends in Opioid Toxicity-Related Deaths in the US Before and After the Start of the COVID-19 Pandemic, 2011-2021.
2011-2021 年美国 COVID-19 大流行前后阿片类药物毒性相关死亡趋势。
JAMA Netw Open. 2023 Jul 3;6(7):e2322303. doi: 10.1001/jamanetworkopen.2023.22303.
4
Liver Function in Patients with Long-Term Coronavirus Disease 2019 of up to 20 Months: A Cross-Sectional Study.长达 20 个月的 2019 年冠状病毒病患者的肝功能:一项横断面研究。
Int J Environ Res Public Health. 2023 Mar 28;20(7):5281. doi: 10.3390/ijerph20075281.
5
The alteration of drug metabolism enzymes and pharmacokinetic parameters in nonalcoholic fatty liver disease: current animal models and clinical practice.非酒精性脂肪性肝病中药代动力学酶和药代动力学参数的改变:当前的动物模型和临床实践。
Drug Metab Rev. 2023 Aug;55(3):163-180. doi: 10.1080/03602532.2023.2202359. Epub 2023 Apr 28.
6
The impact of COVID-19 on liver injury in various age.新型冠状病毒肺炎对不同年龄段肝损伤的影响。
World J Virol. 2023 Mar 25;12(2):91-99. doi: 10.5501/wjv.v12.i2.91.
7
Epigenetic Mechanisms Contribute to Intraindividual Variations of Drug Metabolism Mediated by Cytochrome P450 Enzymes.表观遗传机制导致细胞色素 P450 酶介导的药物代谢的个体内差异。
Drug Metab Dispos. 2023 Jun;51(6):672-684. doi: 10.1124/dmd.122.001007. Epub 2023 Mar 27.
8
Current and emerging medications for the management of obesity in adults.用于成人肥胖管理的现有及新出现的药物。
Med J Aust. 2023 Apr 3;218(6):276-283. doi: 10.5694/mja2.51871. Epub 2023 Mar 19.
9
Prebiotic Consumption Alters Microbiota but Not Biological Markers of Stress and Inflammation or Mental Health Symptoms in Healthy Adults: A Randomized, Controlled, Crossover Trial.益生元摄入改变健康成年人的微生物群,但不影响压力、炎症或心理健康症状的生物学标志物:一项随机对照交叉试验。
J Nutr. 2023 Apr;153(4):1283-1296. doi: 10.1016/j.tjnut.2023.02.015. Epub 2023 Feb 24.
10
MicroRNA-mRNA networks are dysregulated in opioid use disorder postmortem brain: Further evidence for opioid-induced neurovascular alterations.微小RNA-信使核糖核酸网络在阿片类药物使用障碍尸检大脑中失调:阿片类药物诱导神经血管改变的进一步证据。
Front Psychiatry. 2023 Jan 12;13:1025346. doi: 10.3389/fpsyt.2022.1025346. eCollection 2022.